BIBAWO MEDICAL Pvt. Ltd. was established in India in the year 2017. The company received its approval for HYDROZID® in 2020. The head office is in Mumbai headed by a Chairman and Managing Director
BIBAWO MEDICAL Pvt. Ltd. is led by it’s Board of Directors:
Ole Kjerulf-Jensen is the director of the board in Ferring Lægemidler A/S. Ole brings more than 45 years of experience from the international scene in the pharmaceutical industry and has been vital to the global success of Pentasa. Ole is considered a trustful person with the eagerness to make his peers and companies succeed in a global sphere whilst bringing value to both patients, colleagues as well as stakeholders.
Dr. Ashok Alate
Ashok Alate in the beginning of his career worked as a medical oncologist at the Tata Memorial Hospital in Mumbai from 1974-1984; where he also obtained a Ph.D in oncology (1977). Later he received an MBA from University of Mumbai (1980 specialising in marketing.Prior to establishing BIBAWO MEDICAL Pvt. Ltd., Ashok has worked in leadership positions in Cyanamid USA, Asta Werke AG, Nippon Kayaku, Upjohn, Ferring SA, etc. Ashok Alate is currently on the board of two other healthcare MNCs.
Mr. Christian Kjerulf-Jensen
Christian Kjerulf-Jensen is the owner and chief executive officer of BIBAWO MEDICAL Pvt. Ltd. Christian brings with him solid experience in sales and marketing from the pharmaceutical industry as a Senior Product Director in Lundbeck A/S, prior to establishing his own European pharmaceutical company Medilink and later BIBAWO MEDICAL Pvt. Ltd. for medical devices. Academically, Christian achieved an Executive MBA from Copenhagen Business School. Christians knowledge, can-do approach and it is always possible, and eager to make Hydrozid a global success are some of the key elements to his profile.
Cristina Teixeira is the vice president of operations at BIBAWO MEDICAL Pvt. Ltd. Cristina has worked her way up in the organization and today has more than 5 five years of rich management experience. Since summer of 2020 Cristina is pursuing an Executive MBA at Copenhagen Business School on top of her other academic achievements as MSc in Food Science specialized in Chemical Microbiology from Copenhagen University and BSc in Clinical Human Nutrition from Porto University (Portugal) . Cristina has been key to the development of Hydrozid and been one of the main drivers of the regulatory process in India, USA and the EU alongside her responsibility of operations.